Crossmark

Structure–activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures

Crossref DOI link: https://doi.org/10.1016/j.bmc.2015.01.049

Published Print: 2015-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nowotarski, Shannon L.

Pachaiyappan, Boobalan

Holshouser, Steven L.

Kutz, Craig J.

Li, Youxuan

Huang, Yi

Sharma, Shiv K.

Casero, Robert A. Jr.

Woster, Patrick M.
Funding

Funding for this research was provided by:

NIH

NCI (5RO1 CA149095, CA051085)

Samuel Waxman Cancer Research Foundation
License Information

Text and Data Mining valid from 2015-04-01
More Information

This article is maintained by: Elsevier

Article Title: Structure–activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures

Journal Title: Bioorganic & Medicinal Chemistry

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bmc.2015.01.049

Content Type: article

Copyright: Copyright © 2015 Elsevier Ltd. All rights reserved.